In the December announcement, they said "Trial planning has commenced with enrolment of first patients expected to commence in the March quarter of 2022" . If they had difficulties recruiting in that timeframe, I would've thought an announcement should be made in April for an update.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-102
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 3175804 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2861133 | 6 |
View Market Depth
| Last trade - 07.00am 05/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable